EU TRANSPARENCY REGISTER · 363084497287-27 · Sweden

Diamyd Medical AB

Category

Companies & groups

Country

Sweden

Stockholm

Entity form

PLC

Stated objectives

Diamyd Medical develops precision medicine therapies for the prevention and treatment of autoimmune diabetes. Retogatein (rhGAD65) formulated with alum is an investigational antigen-specific immunotherapy, designed to induce antigen-specifi…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2025-03-03

Last updated

2026-03-01

Other Companies & groups in Sweden

Other registered organisations in Sweden

Frequently asked questions

What is this organisation?
Diamyd Medical AB is an interest representative listed in the EU Joint Transparency Register under ID 363084497287-27. Entity form: PLC.
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in Sweden, Stockholm.
What are its stated goals?
As declared by the registrant: Diamyd Medical develops precision medicine therapies for the prevention and treatment of autoimmune diabetes. Retogatein (rhGAD65) formulated with alum is an investigational antigen-specific immunotherapy, designed to induce antigen-specifi…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 363084497287-27.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-04 · Commission Reuse Decision 2011/833/EU